Design and Validation of FEXO: A Playful Exercise Program for Institutionalized Frail Older Adults
FEXO-FRAIL
Design, Development, and Validation of FEXO: A Playful-Recreational Exercise Intervention for Institutionalized Frail Older Adults to Improve Intrinsic Functional and Cognitive Capacity: A Randomized Controlled Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
This multicenter randomized controlled trial aims to evaluate the effectiveness of a playful multicomponent exercise intervention (FEXO - Fun Exercise for Older Adults) on intrinsic capacity, frailty, and functional health in institutionalized older adults aged over 75. The FEXO program combines aerobic, strength, balance, and flexibility training in a recreational format. Participants will be randomized to an experimental group (receiving the 14-week FEXO program) or a wait-list control group (continuing daily routines). After the first intervention phase, the control group will also complete the program. Primary outcomes include improvements in intrinsic capacity domains (cognition, locomotion, vitality, sensory, and psychological), frailty phenotype (Fried criteria), and physical function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2025
CompletedFirst Posted
Study publicly available on registry
August 21, 2025
CompletedStudy Start
First participant enrolled
September 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 19, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 21, 2026
April 1, 2026
4 months
July 25, 2025
April 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Intrinsic Capacity (IC)
This composite outcome evaluates changes in intrinsic capacity, following the five-domain model proposed by the World Health Organization: cognition, vitality, locomotion (function), sensory function, and psychological well-being. Each domain is assessed through one standardized test: the Mini-Mental State Examination (MMSE) for cognition, the Mini Nutritional Assessment (MNA) for vitality, the Short Physical Performance Battery (SPPB) for locomotion, self-reported vision and hearing for sensory function, and the Cornell Scale for Depression in Dementia (CSDD) for psychological well-being. Each test contributes up to a maximum of 2 points, according to predefined cut-off values. For the cognitive domain (MMSE), 2 points are assigned if ≥27, 1 point if 10-26, and 0 points if 0-9. For vitality (MNA), 2 points are assigned if 24-30, 1 point if 17-23, and 0 points if \<17. For locomotion (SPPB), 2 points are assigned if ≥10, 1 point if 3-9, and 0 points if 0-2. For sensory function (self-r
Before and inmediately after the intervention
Frailty (Fried's Phenotype)
Frailty status will be assessed using Fried's phenotype, which classifies participants as robust (0 criteria), pre-frail (1-2 criteria), or frail (3-5 criteria) based on five components: unintentional weight loss, exhaustion, low physical activity, slow gait speed, and weak grip strength. Improvement is defined as transition to a lower frailty category (e.g., from frail to pre-frail).
Before and inmediately after the intervention
Secondary Outcomes (12)
Short Physical Performance Battery (SPPB)
Before and inmediately after the intervention
Timed Up and Go Test (TUG)
Before and inmediately after the intervention
Grip Strength (JAMAR Dynamometer)
Before and inmediately after the intervention
10-Meter Walk Test (10-MWT)
Before and inmediately after the intervention
Mini-Mental State Examination (MMSE)
Before and inmediately after the intervention
- +7 more secondary outcomes
Study Arms (2)
Wait-List Control Group
NO INTERVENTIONParticipants in this group will continue their usual daily activities for 14 weeks without receiving the FEXO intervention. After this period, they will be offered the same 14-week FEXO program as the experimental group, following the same structure, supervision, and exercise content.
FEXO Multicomponent Playful Exercise
EXPERIMENTALParticipants in this group will follow the FEXO program, a 14-week multicomponent playful-recreational exercise intervention. The program includes 3 supervised sessions per week (55-60 minutes each) and incorporates aerobic, resistance, balance, flexibility, and gait exercises delivered in a playful group-based format using motivational materials. The 14-week program is structured into an initial 2-week familiarization phase followed by three progressive 4-week levels. Exercises are adapted and progressively intensified according to individual capacity.
Interventions
A 14-week supervised multicomponent playful exercise program for institutionalized older adults. It consists of 3 sessions per week (55-60 minutes), including aerobic, strength, balance, flexibility, and gait exercises in a group-based, game-like setting. The structure includes 2 weeks of familiarization followed by 3 progressive 4-week levels. The intervention aims to improve intrinsic capacity, reduce frailty, and enhance physical and cognitive function.
Eligibility Criteria
You may qualify if:
- Age ≥75 years.
- Resident in a long-term care facility (residencia geriátrica) affiliated with the Ballesol group (Levante area: Valencia and Alicante).
- Provide informed consent (or consent by legal representative, if appropriate).
- Functional and/or cognitive status that allows them to participate in basic physical activity and understand and follow basic verbal instructions.
You may not qualify if:
- Unstable medical condition or uncontrolled chronic disease.
- Severe cognitive impairment or advanced dementia that prevents comprehension or adherence to the intervention, determined by clinical assessment or MMSE \<15.
- Severe physical disability.
- Active infectious disease or acute condition requiring isolation or rest.
- Participation in another structured physical activity or rehabilitation program during the study period.
- End-of-life situation or terminal illness.
- Any condition that, in the judgment of the research or clinical team, would interfere with participation or data collection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad CEU Cardenal Herrera
Valencia, 46115, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juan Francisco Lisón Párraga, Dr
Cardenal Herrera University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 25, 2025
First Posted
August 21, 2025
Study Start
September 4, 2025
Primary Completion
December 19, 2025
Study Completion
December 31, 2025
Last Updated
April 21, 2026
Record last verified: 2026-04